心脏术后脓毒症患者使用多黏菌素B固定纤维柱选择性吸附脂多糖
该单中心研究纳入143例脓毒症患者,其中103例成人接受Toraymyxin-PMX-20R柱脂多糖吸附,历史对照组30例成人仅接受保守治疗,另有10名儿童(6.2-14 kg)接受Toraymyxin-PMX-0.5R血液灌流。脂多糖吸附疗程后观察到血流动力学和呼吸参数改善,降钙素原和内毒素活性测定下降,白细胞增多改善及体温正常化。研究组28天生存率53%,对照组30%(P=0.037),儿童选择性血液灌流28天生存率90%。作者认为在较大心血管脓毒症患者群体中使用选择性血液灌流的经验显示这些操作安全有效。
要点
- 心脏术后脓毒症成人接受Toraymyxin-PMX-20R脂多糖吸附后28天生存率53%,仅保守治疗的历史对照组为30%(P=0.037)。
- 10名儿童(6.2-14 kg)接受Toraymyxin-PMX-0.5R血液灌流,28天生存率90%。
- 脂多糖吸附疗程后血流动力学和呼吸参数改善,降钙素原和内毒素活性测定下降。
- 作者认为该单中心经验显示选择性血液灌流在心血管脓毒症患者中安全有效。
适用人群与场景
- 成人心脏外科术后脓毒症患者(研究组103例接受脂多糖吸附,历史对照组30例仅保守治疗)。
- 儿童患者10名(体重6.2-14 kg)接受Toraymyxin-PMX-0.5R血液灌流。
处置流程与药物剂量
- 成人脓毒症患者接受脂多糖吸附使用Toraymyxin-PMX-20R柱。
- 儿童(6.2-14 kg)接受血液灌流使用Toraymyxin-PMX-0.5R柱。
研究设计与关键结果
- 单中心研究纳入143例脓毒症患者,其中103例成人接受Toraymyxin-PMX-20R脂多糖吸附,历史对照组30例成人仅接受保守治疗,10名儿童(6.2-14 kg)接受Toraymyxin-PMX-0.5R血液灌流。
- 脂多糖吸附疗程后血流动力学和呼吸参数改善,降钙素原和内毒素活性测定下降,白细胞增多改善,体温正常化。
- 研究组28天生存率53%,对照组30%(P=0.037)。
- 接受选择性血液灌流的儿童28天生存率90%。
证据类型、等级与局限
- 单中心研究,历史对照组设计。
- 作者认为该经验显示选择性血液灌流在心血管脓毒症患者中安全有效。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为在心血管脓毒症患者中使用选择性血液灌流安全有效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis remains the leading cause of morbidity and mortality in intensive care units. The extracorporeal therapy in the complex treatment of sepsis seems to be the most promising direction. The aim of this study was to assess the safety and effectiveness of selective endotoxin adsorption on the basis of the analysis of our own experience with the intensive therapy for sepsis in adult cardiac surgical patients. Our single-center study included 143 patients with sepsis. One hundred and three adult patients received lipopolysaccharide adsorption procedures using Toraymyxin-PMX-20R columns. The historical control group included 30 adult patients received only conservative therapy, and 10 children (6.2-14 kg) received hemoperfusion with Toraymyxin-PMX-0.5R. After the lipopolysaccharide-adsorption course, we noted improving of the hemodynamic and respiratory parameters. A favorable effect of hemoperfusion was a decrease procalcitonin and endotoxin activity assay, expressed by changes of leukocytosis, a normalization of body temperature. The 28-day survival was 53% in the study group and 30% in the control group (P = 0.037). The 28-day survival of children who received selective hemoperfusion was 90%. Our own experience with the use of selective hemoperfusion in a fairly large group of cardiovascular patients with sepsis showed the safety and efficacy of these procedures.
参考来源
- Yaroustovsky M, Abramyan M, Komardina E, et al. Selective LPS Adsorption Using Polymyxin B-Immobilized Fiber Cartridges in Sepsis Patients Following Cardiac Surgery. Shock. 2018. PMID: 28991050. doi:10.1097/SHK.0000000000001016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。